Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2005
08/17/2005CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/16/2005US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide
08/16/2005US6930131 Hetero or aromatic-alkyloxyalkylphenylsulfonamide or analogs or derivatives useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia
08/16/2005US6930117 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
08/16/2005US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals
08/16/2005US6930111 Substituted heterocyclic compounds
08/16/2005US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders
08/16/2005US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives
08/16/2005US6930102 16-halogen-epothilone derivatives, process for their production, and their pharmaceutical use
08/16/2005CA2342974C Methods and compositions for inhibition of angiogenesis
08/16/2005CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them
08/16/2005CA2220438C (n-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents
08/11/2005WO2005073230A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/11/2005WO2005073227A2 A process for the preparation of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] phenyl methyl] thiazolidine-2, 4-dione maleate
08/11/2005WO2005073226A1 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
08/11/2005WO2005073225A1 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
08/11/2005WO2005073224A2 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005WO2005073216A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073203A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
08/11/2005WO2005073202A1 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
08/11/2005WO2005073195A2 Hcv ns-3 serine protease inhibitors
08/11/2005WO2005073192A1 Novel piperidines as chemokine modulators (ccr)
08/11/2005WO2005072732A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/11/2005WO2005072729A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/11/2005WO2005072376A2 Anionic-sweetener-based ionic liquids and methods of use thereof
08/11/2005WO2005072308A2 Cgrp receptor antagonists
08/11/2005WO2005072132A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005034856A3 Targeted drug-formaldehyde conjugates and methods of making and using the same
08/11/2005WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression
08/11/2005US20050176965 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors
08/11/2005US20050176964 Nicotinamide derivatives useful as p38 inhibitors
08/11/2005US20050176801 Acyl bicyclic derivatives of pyrrol
08/11/2005US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis
08/11/2005US20050176789 Modulators of ATP-Binding Cassette transporters
08/11/2005US20050176787 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
08/11/2005US20050176776 Mitotic kinesin inhibitors
08/11/2005US20050176775 Substituted pyridinones
08/11/2005US20050176773 Antimetastasis agents e.g. 6-[4-Amino-5-(2,6-difluoro-benzoyl)-thiazol-2-ylamino]-N-2-dimethylamino-2-methyl-propyl)-nicotinamide; protein kinase inhibitor
08/11/2005US20050176767 Pyridine carboxamide and methods for inhibiting HIV integrase
08/11/2005US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one
08/11/2005US20050176763 Administering a therapeutically effective amount of 3-thia-4-(2-oxy/hydroxyphenyl)quinolin-2-one derivative to a patient to treat erectile dysfunction or irritable bowel syndrome
08/11/2005US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders
08/11/2005US20050176749 Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/11/2005US20050176727 Male erectile dysfunction; 1-(3-chlorophenyl)-3-(4-pyridin-2-yl-piperazin-1-yl)propan-1-one O-methyloxime
08/11/2005US20050176726 Pyrimidine ether derivatives; antiinflammatory; analgesic; antiarthritis; antirheumatic;diseases involving sensory nerve function; 2-((6-(4-((1S)-1-(4-fluorophenyl)ethyl)-1-piperazinyl)-4-pyrimidinyl)oxy)quinoline
08/11/2005US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
08/11/2005US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis
08/11/2005US20050176716 (2,3-5,6 aryl-heteroaryl)-bicyclo(2,2,2,)octane-amide derivatives; antiinflammatory, obesity, antidiabetic agent, autoimmune disease, asthma, arthritis; non-steroidal; side effect reduction; pharmacokinetics
08/11/2005US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
08/11/2005US20050176712 Integrin expression inhibitor
08/11/2005US20050176709 Selective NPY (Y5) antagonists
08/11/2005US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof
08/11/2005DE102004003812A1 Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl substituted heterocycles, processes for their preparation and their use as medicaments
08/11/2005CA2554925A1 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
08/11/2005CA2554525A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/11/2005CA2554389A1 Anionic-sweetener-based ionic liquids and methods of use thereof
08/11/2005CA2554351A1 Cgrp receptor antagonists
08/11/2005CA2553433A1 Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005CA2553089A1 Novel piperidines as chemokine modulators (ccr)
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/11/2005CA2551142A1 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1560827A1 Anti-infective agents
08/10/2005EP1560822A1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors
08/10/2005EP1560817A1 Methods and compositions of novel triazine compounds
08/10/2005EP1560811A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
08/10/2005EP1560580A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
08/10/2005EP1560576A2 Synthesis of oligomeric epicatechin and catechin-derived procyanidins
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP1098891B1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments
08/10/2005CN1653054A Benzoxazine derivatives as 5-HT6 modulators and uses thereof
08/10/2005CN1653053A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
08/10/2005CN1653051A Substituted anthranilamides for controlling invertebrate pests
08/10/2005CN1653049A Pesticidal pyridinecarboxamide derivatives
08/10/2005CN1653048A Pyridine carboxamide derivatives and their use as pesticides
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1652788A Method of treating diabetes
08/10/2005CN1652787A Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
08/10/2005CN1652780A Diaminothiazoles used as CDK4 inhibitors
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/10/2005CN1214040C Peptide derivatives having thiazolyl-alanine residue
08/10/2005CN1214026C Indol-3-yl derivatives
08/10/2005CN1213658C Picolinamide derivatives and pest controllers containing same as active ingredient
08/09/2005US6927230 Triazole derivatives
08/09/2005US6927229 Difluorothioacetamides of oxazolidinones as antibacterial agents
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005US6927216 Treatment of inflammatory disorders
08/09/2005US6927214 Non-peptide GLP-1 agonists
08/09/2005CA2231700C Prodrugs of aspartyl protease inhibitors
08/09/2005CA2188164C Benzamide compounds and pharmaceutical use thereof
08/04/2005WO2005070934A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
08/04/2005WO2005070929A1 Vanilloid receptor ligands and their use in treatments
08/04/2005WO2005070926A1 Thiazole derivatives as a2b antagonists
08/04/2005WO2005070925A1 Aryl substituted heterocycles, method for production and use thereof as medicaments
1 ... 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 ... 628